The Heparin Calcium Market Is Estimated To Witness High Growth Owing To Increasing demand of anticoagulants & increasing cases of coagulation disorders

 
Heparin Calcium Market

The Heparin Calcium Market is estimated to be valued at US$ 1,370.9 Mn in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Heparin calcium is an anticoagulant (blood thinner) drug extracted from animal tissues. It acts as an anticoagulant by inhibiting blood coagulation through a combination of prolonging thrombin time, inhibiting thrombin, disabling its interaction with factors V, VIII and fibrinogen, and increasing the activity of antithrombin III. It is mainly used to prevent blood clots from forming in blood vessels, arteries and veins during procedures such as dialysis, blood transfusions and cardiac surgery.

Market Dynamics:
The heparin calcium market is driven by increasing demand for anticoagulants and growing prevalence of coagulation disorders such as deep vein thrombosis (DVT), pulmonary embolism and atrial fibrillation. According to Centers for Disease Control and Prevention (CDC), atrial fibrillation affects over 2.7 million Americans annually. The risk of developing atrial fibrillation increases with age and the condition is more prevalent in men than women. Moreover, growing geriatric population base that is prone to chronic diseases and coagulation disorders is also expected to boost market growth during the forecast period.

SWOT Analysis

Strength: Heparin calcium market has various clinical applications such as acute coronary syndrome, atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Significant research and development activities by market players to develop new drugs are expected to drive market growth.

Weakness: Stringent regulations for the approval of heparin drugs can hamper market growth. Adverse effects associated with heparin use such as bleeding risks pose challenges.

Opportunity: Increasing prevalence of cardiovascular diseases and venous thromboembolism presents lucrative growth opportunities. Growing healthcare expenditure in emerging economies provides scope for market expansion.

Threats: Expiry of patents leads to decline in sales of branded drugs. Heavy dependence on China for raw material supply acts as a threat.

Key Takeaways

The Global Heparin Calcium Market is expected to witness high growth, exhibiting CAGR of 2.7% over the forecast period, due to increasing prevalence of cardiovascular diseases. The market size for 2022 is estimated to be US$ 1,370.9 Mn.

Regional analysis

North America dominates the global market and is projected to retain its dominance over the forecast period. This is attributed to growing prevalence of chronic diseases, rising healthcare expenditure, and presence of major players in the region. Asia Pacific exhibits the fastest growth due to large patient population, improving access to healthcare facilities, and rising healthcare expenditure in countries such as China and India.

Key players

Key players operating in the heparin calcium market include Sanofi, Pfizer Inc, Dongying Tiandong Pharmaceutical Co., Ltd., PANPHARMA S.A., Merck KGaA, Teva Pharmaceutical Industries Ltd., SMITHFIELD BIOSCIENCE, Afine Chemicals Limited, Yino Pharma Limited, and Shandong Sheelian Pharmaceutical Co., Ltd. Companies are increasingly investing in research and development activities to develop innovative heparin calcium drugs.

Read More - https://www.dailyprbulletin.com/promising-growth-opportunities-to-steer-the-heparin-calcium-market-towards-new-heights/

Comments

Post a Comment

Popular posts from this blog

Training Market Estimated To Witness High Growth Owing To Growing Emphasis on Developing Skillset

Image
  Training Market The Training Market Is Estimated To Be Valued At US$132.2244 Bn In 2023 And Is Expected To Exhibit A CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The training market covers products and services related to developing and enhancing skills through workshops, online programs and classroom instructions. This includes corporate training focused on technical, soft and safety skills for varied industries. The key end users are corporates, government organizations and educational institutes. Market Dynamics: The training market is expected to witness significant growth owing to growing emphasis on developing skills to cope with rising complexity and changing nature of jobs. With rapid digitalization and emerging technologies, job roles are transforming significantly necessitating continuous upskilling and reskilling of workforce. This is driving increased demand for training p...
Read more

Salmonella Testing Is Estimated To Witness High Growth Owing To Rising Food Safety Concerns

Image
Salmonella testing market The Salmonella testing market is estimated to be valued at US$ 2.91 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Salmonella testing market involves detection and identification of Salmonella bacteria that causes food poisoning. The key products in the market are assays, kits and reagents that are used to test food samples, clinical samples and environmental samples for the presence of Salmonella. Major end-users include food processing companies, pharmaceutical companies, clinical laboratories and research institutions. Market Dynamics: Rising global outbreaks of foodborne illnesses caused by Salmonella infection is a major factor driving growth of the Salmonella testing market. According to WHO, non-typhoidal Salmonella causes over 90 million cases of gastroenteritis each year globally. Growing consumer awareness abo...
Read more

Global Lab-on-a-Chip and Microarrays (Biochip) Market Is Estimated To Witness High Growth Owing To Rising Demand for Personalized Medicine and Technological Advancements

Image
  Lab-on-a-Chip and Microarrays (Biochip) Market The Lab-on-a-Chip and Microarrays (Biochip) Market is estimated to be valued at US$ 15,268.0 Mn in 2023 and is expected to exhibit a CAGR of 13.43% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Lab-on-a-chip and microarrays (biochip) are innovative technologies that have revolutionized the field of diagnostics and drug discovery. These devices are used for sample analysis and detection of diseases at a molecular level. Lab-on-a-chip platforms offer benefits such as minimal sample requirement, high-throughput analysis, and cost-effective solutions. They find applications in various areas such as genomics, proteomics, and clinical diagnostics, among others. These biochips have the potential to provide personalized medicine by enabling rapid and accurate diagnosis, leading to effective treatments and improved patient outcomes. Market Dynamics: The market ...
Read more